Rapirosiran sodium
Rapirosiran sodium is a small interfering RNA conjugated with N-acetylgalactosamine that targets the mRNA of hydroxysteroid 17-β dehydrogenase 13 (HSD17B13) expressed in the liver. Loss-of-function variants of HSD17B13 are associated with a reduced risk of chronic liver diseases.
Product Specifications
CAS Number
2755197-77-2
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS4382018-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
INSM1 (Pan-Neuroendocrine Marker) Recombinant Rabbit Monoclonal Antibody [Clone INSM1/6286R]
Sign In for Pricing
View Details MBS4382018-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
INSM1 (Pan-Neuroendocrine Marker) Recombinant Rabbit Monoclonal Antibody [Clone INSM1/6286R]
Sign In for Pricing
View Details MBS4382018-03 0.1 mg (Without BSA & Azide at 1mg/mL)
INSM1 (Pan-Neuroendocrine Marker) Recombinant Rabbit Monoclonal Antibody [Clone INSM1/6286R]
Sign In for Pricing
View Details MBS4382018-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
INSM1 (Pan-Neuroendocrine Marker) Recombinant Rabbit Monoclonal Antibody [Clone INSM1/6286R]
Sign In for Pricing
View Details MBS4382018-05 5x 0.1 mg (Without BSA & Azide at 1mg/mL)
INSM1 (Pan-Neuroendocrine Marker) Recombinant Rabbit Monoclonal Antibody [Clone INSM1/6286R]
Sign In for Pricing
View Details